img

Global Sickle Cell Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Sickle Cell Market Research Report 2024

The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.
According to MRAResearch’s new survey, global Sickle Cell market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sickle Cell market research.
The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Sickle Cell market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis
Bristol-Myers Squibb
Takeda
Bluebird Bio
Global Blood Therapeutics
Segment by Type
Diagnosis
Treatment

Segment by Application


Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Sickle Cell report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Sickle Cell Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Market Perspective (2018-2033)
2.2 Sickle Cell Growth Trends by Region
2.2.1 Global Sickle Cell Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Sickle Cell Historic Market Size by Region (2018-2023)
2.2.3 Sickle Cell Forecasted Market Size by Region (2024-2033)
2.3 Sickle Cell Market Dynamics
2.3.1 Sickle Cell Industry Trends
2.3.2 Sickle Cell Market Drivers
2.3.3 Sickle Cell Market Challenges
2.3.4 Sickle Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Players by Revenue
3.1.1 Global Top Sickle Cell Players by Revenue (2018-2023)
3.1.2 Global Sickle Cell Revenue Market Share by Players (2018-2023)
3.2 Global Sickle Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Revenue
3.4 Global Sickle Cell Market Concentration Ratio
3.4.1 Global Sickle Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Revenue in 2022
3.5 Sickle Cell Key Players Head office and Area Served
3.6 Key Players Sickle Cell Product Solution and Service
3.7 Date of Enter into Sickle Cell Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Breakdown Data by Type
4.1 Global Sickle Cell Historic Market Size by Type (2018-2023)
4.2 Global Sickle Cell Forecasted Market Size by Type (2024-2033)
5 Sickle Cell Breakdown Data by Application
5.1 Global Sickle Cell Historic Market Size by Application (2018-2023)
5.2 Global Sickle Cell Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Sickle Cell Market Size (2018-2033)
6.2 North America Sickle Cell Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Sickle Cell Market Size by Country (2018-2023)
6.4 North America Sickle Cell Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sickle Cell Market Size (2018-2033)
7.2 Europe Sickle Cell Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Sickle Cell Market Size by Country (2018-2023)
7.4 Europe Sickle Cell Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Market Size (2018-2033)
8.2 Asia-Pacific Sickle Cell Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Sickle Cell Market Size by Region (2018-2023)
8.4 Asia-Pacific Sickle Cell Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sickle Cell Market Size (2018-2033)
9.2 Latin America Sickle Cell Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Sickle Cell Market Size by Country (2018-2023)
9.4 Latin America Sickle Cell Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Market Size (2018-2033)
10.2 Middle East & Africa Sickle Cell Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Sickle Cell Market Size by Country (2018-2023)
10.4 Middle East & Africa Sickle Cell Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Sickle Cell Introduction
11.1.4 Novartis Revenue in Sickle Cell Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Sickle Cell Introduction
11.2.4 Bristol-Myers Squibb Revenue in Sickle Cell Business (2018-2023)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Takeda
11.3.1 Takeda Company Detail
11.3.2 Takeda Business Overview
11.3.3 Takeda Sickle Cell Introduction
11.3.4 Takeda Revenue in Sickle Cell Business (2018-2023)
11.3.5 Takeda Recent Development
11.4 Bluebird Bio
11.4.1 Bluebird Bio Company Detail
11.4.2 Bluebird Bio Business Overview
11.4.3 Bluebird Bio Sickle Cell Introduction
11.4.4 Bluebird Bio Revenue in Sickle Cell Business (2018-2023)
11.4.5 Bluebird Bio Recent Development
11.5 Global Blood Therapeutics
11.5.1 Global Blood Therapeutics Company Detail
11.5.2 Global Blood Therapeutics Business Overview
11.5.3 Global Blood Therapeutics Sickle Cell Introduction
11.5.4 Global Blood Therapeutics Revenue in Sickle Cell Business (2018-2023)
11.5.5 Global Blood Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sickle Cell Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Sickle Cell Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Sickle Cell Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Sickle Cell Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Sickle Cell Market Share by Region (2018-2023)
Table 8. Global Sickle Cell Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Sickle Cell Market Share by Region (2024-2033)
Table 10. Sickle Cell Market Trends
Table 11. Sickle Cell Market Drivers
Table 12. Sickle Cell Market Challenges
Table 13. Sickle Cell Market Restraints
Table 14. Global Sickle Cell Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Sickle Cell Market Share by Players (2018-2023)
Table 16. Global Top Sickle Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell as of 2022)
Table 17. Ranking of Global Top Sickle Cell Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Sickle Cell Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sickle Cell Product Solution and Service
Table 21. Date of Enter into Sickle Cell Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sickle Cell Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Sickle Cell Revenue Market Share by Type (2018-2023)
Table 25. Global Sickle Cell Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Sickle Cell Revenue Market Share by Type (2024-2033)
Table 27. Global Sickle Cell Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Sickle Cell Revenue Market Share by Application (2018-2023)
Table 29. Global Sickle Cell Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Sickle Cell Revenue Market Share by Application (2024-2033)
Table 31. North America Sickle Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Sickle Cell Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Sickle Cell Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Sickle Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Sickle Cell Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Sickle Cell Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Sickle Cell Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Sickle Cell Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Sickle Cell Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Sickle Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Sickle Cell Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Sickle Cell Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Sickle Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Sickle Cell Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Sickle Cell Market Size by Country (2024-2033) & (US$ Million)
Table 46. Novartis Company Detail
Table 47. Novartis Business Overview
Table 48. Novartis Sickle Cell Product
Table 49. Novartis Revenue in Sickle Cell Business (2018-2023) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Bristol-Myers Squibb Company Detail
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb Sickle Cell Product
Table 54. Bristol-Myers Squibb Revenue in Sickle Cell Business (2018-2023) & (US$ Million)
Table 55. Bristol-Myers Squibb Recent Development
Table 56. Takeda Company Detail
Table 57. Takeda Business Overview
Table 58. Takeda Sickle Cell Product
Table 59. Takeda Revenue in Sickle Cell Business (2018-2023) & (US$ Million)
Table 60. Takeda Recent Development
Table 61. Bluebird Bio Company Detail
Table 62. Bluebird Bio Business Overview
Table 63. Bluebird Bio Sickle Cell Product
Table 64. Bluebird Bio Revenue in Sickle Cell Business (2018-2023) & (US$ Million)
Table 65. Bluebird Bio Recent Development
Table 66. Global Blood Therapeutics Company Detail
Table 67. Global Blood Therapeutics Business Overview
Table 68. Global Blood Therapeutics Sickle Cell Product
Table 69. Global Blood Therapeutics Revenue in Sickle Cell Business (2018-2023) & (US$ Million)
Table 70. Global Blood Therapeutics Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Sickle Cell Market Share by Type: 2022 VS 2033
Figure 3. Diagnosis Features
Figure 4. Treatment Features
Figure 5. Global Sickle Cell Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Sickle Cell Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Sickle Cell Report Years Considered
Figure 11. Global Sickle Cell Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Sickle Cell Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Sickle Cell Market Share by Region: 2022 VS 2033
Figure 14. Global Sickle Cell Market Share by Players in 2022
Figure 15. Global Top Sickle Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Sickle Cell Revenue in 2022
Figure 17. North America Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Sickle Cell Market Share by Country (2018-2033)
Figure 19. United States Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Sickle Cell Market Share by Country (2018-2033)
Figure 23. Germany Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Sickle Cell Market Share by Region (2018-2033)
Figure 31. China Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Sickle Cell Market Share by Country (2018-2033)
Figure 39. Mexico Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Sickle Cell Market Share by Country (2018-2033)
Figure 43. Turkey Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Sickle Cell Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Novartis Revenue Growth Rate in Sickle Cell Business (2018-2023)
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Sickle Cell Business (2018-2023)
Figure 47. Takeda Revenue Growth Rate in Sickle Cell Business (2018-2023)
Figure 48. Bluebird Bio Revenue Growth Rate in Sickle Cell Business (2018-2023)
Figure 49. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed